Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04218708 · ClinicalTrials.gov registry record · NA
Electronic Cigarettes as a Harm Reduction Strategy Among People Living With HIV/AIDS
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT04218708 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 64 participants.
The verdict
NCT04218708, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
This is a research study to understand and determine the effectiveness of electronic cigarettes versus nicotine replacement therapy in adults who smoke and also live with HIV/AIDS in effort to reduce cigarette smoking.
Interventions
- BEHAVIORAL Counseling
- OTHER Nicotine patch and gum
- BEHAVIORAL Minnesota Nicotine Withdrawal Scale (MNWS)
- BEHAVIORAL ASSIST (the Alcohol, Smoking and Substance Involvement Screening)
- OTHER NIDA Standardized Research E-cigarettes (SREC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2021-06-17 |
| Est. Completion | 2024-03-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04218708
The ClinicalTrials.gov registry entry for NCT04218708 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Counseling is the first listed.
NCT04218708 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04218708 about?
NCT04218708 is a clinical study titled "Electronic Cigarettes as a Harm Reduction Strategy Among People Living With HIV/AIDS". This is a research study to understand and determine the effectiveness of electronic cigarettes versus nicotine replacement therapy in adults who smoke and also live with HIV/AIDS in effort to reduce cigarette smoking.
What is the current status of trial NCT04218708?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2021-06-17. Estimated completion is 2024-03-08.
What interventions are being tested in trial NCT04218708?
The interventions under investigation include: Counseling (BEHAVIORAL), Nicotine patch and gum (OTHER), Minnesota Nicotine Withdrawal Scale (MNWS) (BEHAVIORAL), ASSIST (the Alcohol, Smoking and Substance Involvement Screening) (BEHAVIORAL), NIDA Standardized Research E-cigarettes (SREC) (OTHER).
Who is sponsoring clinical trial NCT04218708?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.